[HTML][HTML] Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

NJ Kassebaum, A Bertozzi-Villa, MS Coggeshall… - The Lancet, 2014 - thelancet.com
Summary Background The fifth Millennium Development Goal (MDG 5) established the goal
of a 75% reduction in the maternal mortality ratio (MMR; number of maternal deaths per 100 …

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease …

CJL Murray, KF Ortblad, C Guinovart, SS Lim… - The Lancet, 2014 - thelancet.com
Summary Background The Millennium Declaration in 2000 brought special global attention
to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal …

Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

H Wang, CA Liddell, MM Coates, MD Mooney… - The Lancet, 2014 - thelancet.com
Background Remarkable financial and political efforts have been focused on the reduction
of child mortality during the past few decades. Timely measurements of levels and trends in …

Universal health coverage in Turkey: enhancement of equity

R Atun, S Aydın, S Chakraborty, S Sümer, M Aran… - The Lancet, 2013 - thelancet.com
Turkey has successfully introduced health system changes and provided its citizens with the
right to health to achieve universal health coverage, which helped to address inequities in …

Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial

HG Kanmaz, O Erdeve, FE Canpolat, B Mutlu… - …, 2013 - publications.aap.org
BACKGROUND: The primary aim of this randomized study was to describe the feasibility of
early administration of surfactant via a thin catheter during spontaneous breathing (Take …

Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial

MY Oncel, S Yurttutan, O Erdeve, N Uras, N Altug… - The Journal of …, 2014 - Elsevier
Objective To compare the efficacy and safety of oral paracetamol and oral ibuprofen for the
pharmacological closure of patent ductus arteriosus (PDA) in preterm infants. Study design …

Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants

MY Oncel, S Yurttutan, H Degirmencioglu, N Uras… - Neonatology, 2013 - karger.com
Background: Treatment options for the closure of a hemodynamically significant patent
ductus arteriosus (hsPDA) include medical therapy such as ibuprofen and indomethacin and …

Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial

MY Oncel, FN Sari, S Arayici, N Guzoglu… - Archives of Disease in …, 2014 - fn.bmj.com
Objective To evaluate the effect of oral Lactobacillus reuteri (L reuteri) first on the incidence
and severity of Necrotising enterocolitis (NEC) and second on sepsis. Design Prospective …

Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus

T Gokmen, O Erdeve, N Altug, SS Oguz, N Uras… - The Journal of …, 2011 - Elsevier
OBJECTIVE: To compare oral ibuprofen with intravenous ibuprofen for closure of patent
ductus arteriosus in very low birth weight (VLBW) preterm infants. STUDY DESIGN: In a …

What are the cut‐off levels for IL‐6 and CRP in neonatal sepsis?

İH Celik, FG Demirel, N Uras, SS Oguz… - Journal of clinical …, 2010 - Wiley Online Library
Neonatal sepsis, characterized by systemic signs of infection in the first month of life,
remains an important clinical syndrome. Despite advances in neonatology, it has high rates …